Get to know Addiction Medicine Specialist Dr. Alan A. Wartenberg, who serves patients throughout the State of Rhode Island.
(WorldFrontNews Editorial):- New York City, New York Jun 6, 2024 (Issuewire.com) – An experienced addiction medicine specialist, Dr. Wartenberg is a Medical Director at MAP Health Management, working with patients in Rhode Island.
The mission of MAP Health Management is to leverage their extensive lived experience in behavioral health and substance misuse to improve personal connection, community health, and healthcare outcomes.
More on World Front News Stories:
- Get a 10% Discount on Spotify Promotion Services from The Tunes Club
- Secure 20% Discount on YouTube Promotion Services with the Biggest Black Friday Sale
- The Queensland DJ, Christian Krauter Is Back With Banging Hits
- How an Online Redirect Checker Tool Can Help?
- IssueWire is Here to Help Out with the Press Release Headline and a Lot More
Pertaining to his educational pursuits, Dr. Wartenberg received his Bachelor of Arts degree at New York University and his medical degree at the Medical College of Wisconsin. He completed his rotating internship at Harbor-UCLA Medical Center and his residency in internal medicine at Milwaukee County Medical Center. After 2 years in private practice, he returned to a Faculty Fellowship at the Medical College of Wisconsin as a Career Teacher in Alcohol and Substance Abuse.
Passionate about his profession, the doctor is board-certified in addiction medicine by the American Board of Addiction Medicine (ABAM), which provides assurance to the American public that addiction medicine physicians have the knowledge and skills to prevent, recognize, and treat addiction.
Moreover, he is board-certified in internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.
Achieving fellowship status, Dr. Wartenberg is a Fellow of the American College of Physicians (FACP), and a Distinguished Fellow of the American Society of Addiction Medicine (DFASAM). He is also an Affiliated Faculty Member at the Center for Alcohol and Addiction Studies at Brown University in Providence.
Throughout his illustrious career, he served as the Medical Director of the Addiction Recovery Program at Faulkner Hospital in Boston for 14 years, and was the Corporate Medical Director of Discovery House, a group of outpatient opioid treatment programs, for ten years. He recently retired from the private practice of addiction medicine at the Meadows Edge Recovery Center in Rhode Island and also retired as a consulting physician in the DVA Providence Medical Center Opioid Treatment Program. He has published widely in many areas of substance abuse, including treatment of the elderly, opioid and alcohol detoxification and medical complications of addiction.
Addiction medicine is a medical subspecialty that deals with the diagnosis, prevention, evaluation, treatment, and recovery of persons with addiction, of those with substance-related and addictive disorders, and of people who show unhealthy use of substances including alcohol, nicotine, prescription medicine and other illicit and licit drugs. An addiction medicine physician provides prevention, evaluation, diagnosis, and treatment services for patients with unhealthy substance use or substance-related health conditions.
Learn More about Dr. Alan A. Wartenberg:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/952786-Alan-Wartenberg-Addiction-Medicine-Specialist or through MAP Health Management, https://thisismap.com/about-us/our-team/alan-wartenberg
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
This article was originally published by IssueWire. Read the original article here.